Our study is the first to report the association of the HLA-DQA1 SNP with breast cancer risk in non-Hispanic white women, suggesting that HLA class II plays a decisive role in the pathogenesis of breast cancer in this population by diminishing the efficacy of the antitumoral immune response. Here, HLA-DQA1 is linked to breast cancer.